via Imperial College London
By attaching specialised molecules to the backbone of DNA, researchers have made it easier to detect rare molecules associated with early disease.
The presence of, or changes in the concentration of, certain proteins in biological fluids can be indicators of disease. However, in the early stages of disease these ‘biomarkers’ can be difficult to detect, as they are relatively rare.
We have now shown that this is possible to perform such measurements in real human samples, opening up the potential for meaningful early diagnosis.– Dr Alex Ivanov
Detecting important biomarkers in lower concentrations will allow patients to be treated earlier for diseases such as some cancers and neurological disorders, which could increase the chance of survival rate.
However, current methods of detection are often not sufficiently sensitive and require costly and time-consuming sample pre-treatment.
Now, researchers from the Department of Chemistry at Imperial College London have come up with a system that is specific, flexible, and can detect single protein biomarkers directly in human serum (a pool of fluid separated from blood).
The system represents a significant innovation, as it is more sensitive to specific biomarkers and does not require clinical sample preparation. The method is published in Nature Communications.
Dr Alex Ivanov, co-leader of this study from the Department of Chemistry at Imperial, said: “The detection of single molecules of biomarkers represents the ultimate in sensitivity for early diagnosis. We have now shown that this is possible to perform such measurements in real human samples, opening up the potential for meaningful early diagnosis.”
Binding to biomarkers
The method the team developed uses the ‘backbone’ of DNA, the structure it is built around. They grafted ‘aptamers’ – synthetic DNA molecules that bind to specific target biomarkers – to DNA backbones.
When added to human serum, the aptamers bind to biomarkers before being analysed by passing through a nanopore detector. Nanopores are miniscule holes (often as small as a few billionths of a meter) that measure a change in electrical current as molecules pass through them.
Each biomarker has a unique current signature, so the presence and concentration of target biomarkers can be analysed in this way.
With the rapid growth in nanotechnology and nanopore technology, this innovative platform could pave the way for the next wave of clinical applications.– Dr Jasmine Sze
The team demonstrated that their system can work by testing three aptamers on one DNA backbone. They found that the nanopores can detect the specific biomarkers that the aptamers were designed to pick up.
They say that the system can be constructed with more than five different aptamers, allowing detection of multiple biomarkers at once. In addition, the biomarkers were detected in human serum, meaning far less preparation time and cost were needed.
Based on the preliminary findings of this study, research efforts are now focused on several types of cancer and neurological disorders, which can benefit from the detection of biomarkers that are in low abundance in clinical samples.
The team have filed a patent for the technology, and are currently exploring routes towards commercialisation so that it can be used to ultimately improve quality of life.
Dr Jasmine Sze, who completed this study as part of her PhD in the Department of Chemistry and has recently moved to the IMED Biotech at AstraZeneca said “Looking forward, with the rapid growth in nanotechnology and nanopore technology, this innovative platform could pave the way for the next wave of clinical applications.
“It has great potential for biomarker discovery, development of companion diagnostics as well as clinical endeavours, such as direct diagnosis, prognosis and sub-type classification with single-molecule sensitivity.”
Learn more: Early disease diagnosis could be dramatically improved with new detection system
The Latest on: Disease diagnosis
- Artificial intelligence provides faster diagnosis for debilitating blistering diseaseon July 8, 2021 at 10:10 am
Scientists at the University of Groningen have trained an Artificial Intelligence system to recognize a specific pattern in skin biopsies of patients with the blistering disease epidermolysis bullosa ...
- 75% Of Covid Patients In One Study Still Had Symptoms A Year Lateron July 8, 2021 at 9:40 am
What's believed to be the world's longest-running study on Covid patients has found troubling results—most people infected with Covid-19 had lingering symptoms a year after the initial infection, and ...
- Adults With Obesity See Increased Risk for Crohn's Diseaseon July 8, 2021 at 8:30 am
Obesity in adulthood was associated with a 34% increased risk for developing Crohn's disease, while no such link was seen with ulcerative colitis, a pooled analysis of large prospective studies found.
- Symptoms for the delta variant are different from 'classic' COVID-19 symptoms. Here's what you need to know.on July 8, 2021 at 8:02 am
The highly contagious delta COVID-19 variant is one of the fastest spreading variants, but could also prove to be one of more elusive to diagnose, doctors say. That's because the delta symptoms do not ...
- Zika virus cases in Kerala: Symptoms, prevention and treatment of mosquito-borne diseaseon July 8, 2021 at 7:27 am
There is no specific treatment or vaccine for the Zika virus and the development of the Zika vaccine remains an active area of research, according to the WHO.
- Gene therapy in early stages of Huntington's disease may slow down symptom progressionon July 7, 2021 at 6:50 pm
In a new study on mice, researchers report that using MRI scans to measure blood volume in the brain can serve as a noninvasive way to potentially track the progress of gene editing therapies for ...
- Study: Gene editing therapy for early-stage Huntington’s disease may have long-lasting benefitson July 7, 2021 at 4:59 pm
In a new study on mice, Johns Hopkins Medicine researchers report that using MRI scans to measure blood volume in the brain can serve as a noninvasive way to potentially track the progress of gene ...
- How Crohn's Disease Is Diagnosedon July 6, 2021 at 8:02 pm
Crohn's disease is an inflammatory bowel disease. There is no singular test to diagnose Crohn's disease, and physicians may rely on a variety of testing methods to reach an official diagnosis of Crohn ...
- After Timesia Hart Was Diagnosed With a Rare Disease, She Started a Bike Race to Inspire Otherson July 6, 2021 at 12:23 pm
I’m not supposed to be able to walk, let alone ride. I pray that by riding, others will be inspired to keep pushing.” ...
- Rare Disease Symptoms as a Marker for Rare Disease & Improving Diagnosison July 6, 2021 at 7:00 am
The more we understand about the symptoms of rare diseases, the more accurate genetic diagnosis becomes. This is especially true for genetic syndromes ...
via Google News and Bing News
